Pfizer to sell Pharmacia diagnostics unit
Pfizer is considering the sale of its Pharmacia Diagnostics business, acquired alongside the rest of Pharmacia in a $60 billion deal that concluded in April.
Pfizer is considering the sale of its Pharmacia Diagnostics business, acquired alongside the rest of Pharmacia in a $60 billion deal that concluded in April.
US food company McCormick & Co looks set to sell its packaging activities to Kerr Group in a transaction valued at $142.5 million.
The market for antibacterial drugs is becoming increasingly unattractive to major pharmaceutical companies, despite continued strong worldwide demand for these products and the growing threat of bacterial resistance, according to a report from...
The European Commission has issued its long-awaited response to the G10 Medicines Report, intended as a blueprint for improving the European pharmaceutical industry's competitiveness while ensuring high levels of public health protection.
Former Yugoslav prime minister Milan Panic, who until recently had been at the helm of ICN Pharmaceuticals for 42 years, has bought the ICN Biomedicals division for $15 million.
Switzerland's Tecan has introduced a range of laboratory automation workstations, under the Freedom EVO banner, which are designed to provide fluid handling applications in genomics, proteomics, drug discovery and clinical diagnostics.
Invitrogen has made a cash offer for fellow US company Molecular Probes in a deal which would give the firm a very strong presence in fluorescence reagents for use in labelling molecules for biological research and drug discovery.